Val
—
Gro
—
Qua
—
Mom
—
Sta
—
Cap—
P/S0.72
P/E—
Fwd P/E14.73
PEG1.75
52W— – —
RSI—
Target$98.19 (+11.1%)
Beta0.81
Div—
Loading chart…
RSI ()
Loading patterns…
Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments. The Global Distribution and Value-Added Services segment distributes infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, gypsum, acrylics, articulators, abrasives, PPE products, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, dental chairs, delivery units and lights, digital dental laboratories, X-ray supplies and equipment, and high-tech and digital restoration equipment, as well as provides equipment repair services, financial services on a non-recourse basis, continuing education services for practitioners, consulting, and other services. It also markets and sells a portfolio of consumable merchandise under its own corporate brand. The Global Specialty Products segment engage in manufacturing, marketing, and sales of dental implant and biomaterial products; and endodontic, orthodontic and orthopedic products, and other health care-related products and services. The Global Technology segment is involved in the development and distribution of practice management software, e-services, and other products which are distributed to health care providers. The company serves dental practices, laboratories, physician practices, and ambulatory surgery centers, as well as government, institutional health care clinics, home health providers, and other alternate care clinics. It has a strategic partnership with GoTu Technology to help dental practices address ongoing staffing challenges. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.
Signal
Trend Strength
Price Levels
52-Week Range
52W Low
—
52W High
Position in Range
—
RSI (14)
0 · Oversold
RSI 48
Overbought · 100
Signal
Neutral
EMA Price Levels
Activity & Patterns
Volume Analysis
Momentum Dashboard
Detected Patterns
7Bullish
3Bearish
0Neutral
Key Signals 2
▲ Double Bottom
Major reversal
2026-08-05 · $89.34
Two lows ~$82.77 — bullish reversal confirmed
Learn more →
▼ Double Top
Major reversal
2026-09-10 · $87.67
Two peaks ~$91.62 — bearish reversal confirmed
Learn more →
Momentum Signals 8
▲ MACD Bullish Crossover
▲ Bull Flag
▲ Bull Flag
▲ MACD Bullish Crossover
View overlays on the price chart via Overview tab → Pattern Overlays.
EPS — History & Forecast
Estimate
Beat
Miss
Forecast
Loading…
Revenue — History & Forecast
Revenue
Forecast
Loading…
EPS Beat Rate
75%
6/8 quarters
Wall Street Consensus
BUY
BuyHoldSell
Price Target Range
$98.19
+11.1% upside
Low $64
—
High $112
Consensus
Current price
Wall Street Analyst Ratings
Sort by
| Firm | Rating | Change | Action | Date |
|---|
Profitability
Gross Margin
31.32%Last 12 Months
Operating Margin
5.76%Last 12 Months
Return on Equity
8.85%Last 12 Months
Revenue Growth
6.70%Year over Year
Free Cash Flow
446.00MLast 12 Months
Free Cash Flow Yield
—Last 12 Months
Balance Sheet
Debt / Equity
80.73Most Recent Quarter
Current Ratio
1.32Most Recent Quarter
Cash
157.00MMost Recent Quarter
Total Debt
3.81BMost Recent Quarter
Net Debt
—Most Recent Quarter
How HSIC Makes Its Money
Cash Flow Breakdown
Quarterly Metrics
| Quarter | Revenue | Rev YoY | Gross Profit | Op. Income | Net Income | Net YoY | Gross % | Op % | Net % |
|---|
Full Key Statistics
Valuation
| Market Cap | 9.85B |
| Enterprise Value | 15.07B |
| Trailing P/E | 25.46 |
| Forward P/E | 14.73 |
| PEG Ratio (5yr) | 1.75 |
| Price/Sales (ttm) | 0.72 |
| Price/Book (mrq) | 3.13 |
| EV/Revenue | 1.11 |
| EV/EBITDA | 13.95 |
Share Statistics
| Avg Vol (3m) | 1.22M |
| Shares Outstanding | 111.45M |
| Float | 91.82M |
| % Held by Insiders | 0.83% |
| % Held by Institutions | 111.87% |
| Short Ratio | 7.04 |
| Short % of Float | 8.85% |
Profitability
| Gross Margin | 31.32% |
| Operating Margin (ttm) | 5.76% |
| Profit Margin | 2.96% |
| Return on Assets (ttm) | 4.39% |
| Return on Equity (ttm) | 8.85% |
Income Statement
| Revenue (ttm) | 13.60B |
| Revenue Growth (yoy) | 6.70% |
| Gross Profit (ttm) | 4.26B |
| EBITDA | 1.08B |
| Net Income (ttm) | 403.00M |
| Diluted EPS (ttm) | 3.47 |
| EPS Growth (yoy) | 17.10% |
Balance Sheet
| Total Cash (mrq) | 157.00M |
| Total Debt (mrq) | 3.81B |
| Debt / Equity (mrq) | 80.73 |
| Current Ratio (mrq) | 1.32 |
| Book Value / Share | 28.21 |
| Operating CF (ttm) | 700.00M |
| Free Cash Flow (ttm) | 446.00M |
Trading & Dividends
| Beta (5Y) | 0.81 |
| 50-Day MA | 87.66 |
| 200-Day MA | 79.34 |
| Fwd Dividend Yield | N/A |
| Payout Ratio | 0.00% |
No dividend history available for HSIC.
Ownership Breakdown
Institutional 111.87%
Insider 0.83%
Short Interest
8.85% of float
High
Institutional 13F Holdings
Famous investors who disclosed a position in HSIC in their latest SEC 13F filing.
Loading…
Insider Transactions
| Date | Insider | Role | Transaction | Shares | Price | Value |
|---|